Safety and efficacy of newer biologics DMARDs in the management of rheumatoid arthritis: A systematic review

OBJECTIVE: To analyze the safety and efficacy of certain biologics DMARDs (Adalimumab, Baricitinib, Pefacitinib and Sirukumab) either used alone or as a combination with MTX for management of rheumatoid arthritis. METHOD: We conducted a systematic literature review on various phase 3 Randomized cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Zago, Basiru Ahmad, Priyadharshini, A., Vijayakumar, T.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
REVIEW
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718147/
https://www.ncbi.nlm.nih.gov/pubmed/36474893
http://dx.doi.org/10.1016/j.ocarto.2020.100116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718147/
https://www.ncbi.nlm.nih.gov/pubmed/36474893
http://dx.doi.org/10.1016/j.ocarto.2020.100116

Ejemplares similares